ALLIANCEBERNSTEIN L.P.

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$391,162

+$258,463 QoQ

Shares Held

104,310

+109.9% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#81

of 178 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. CTMX ranks #179 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,019,315	$1,499,784,339
2	ARGX	Argenx SE	395,661	$367,082,405
3	GMAB	Genmab A/S	8,644,877	$237,474,771
4	REGN	Regeneron Pharmaceuticals, Inc.	292,338	$182,284,436
5	TECH	BIO-TECHNE Corp	2,002,026	$141,443,136
6	HALO	Halozyme Therapeutics, Inc.	1,696,538	$132,788,029
7	KYMR	Kymera Therapeutics, Inc.	981,521	$112,551,013
8	BBIO	BridgeBio Pharma, Inc.	1,453,504	$108,256,977

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$391,162	104,310	+109.9%	Shares	Defined	2026-08-14
2022-03-31	$132,699	49,700	+0.4%	Shares	Defined	2022-05-13
2021-12-31	$214,335	49,500	-1.8%	Shares	Defined	2022-02-14
2021-09-30	$256,536	50,400	-11.7%	Shares	Defined	2021-11-10
2021-06-30	$361,443	57,100	+22.0%	Shares	Defined	2021-07-30
2021-03-31	$361,764	46,800	-25.6%	Shares	Defined	2021-05-06
2020-12-31	$411,995	62,900	0.0%	Shares	Defined	2021-02-08
2020-09-30	$418,285	62,900	-2.3%	Shares	Defined	2020-11-12
2020-06-30	$536,452	64,400	0.0%	Shares	Defined	2020-08-13
2020-03-31	$493,948	64,400	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.